外骨髓瘤是基因组复杂的,其特征是近乎普遍的MAPK路径变化
Saurabh Zanwar1, Joseph Novak2, Wilson I Gonsalves2
1Mayo Clinic, rochester, Minnesota, United States.
Blood advances
|May 14, 2025
概括
多发性骨髓瘤 (MM) 的外骨髓性疾病 (EMD) 呈现出明显的分子特征,特别是MAPK路径突变. 在基因组上,EMD瘤是复杂的,与骨髓有很大的不同,这表明了新的治疗点.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 多发性骨髓瘤 (MM) 的外骨髓性疾病 (EMD) 与预后较差和治疗效率降低有关.
- 了解EMD的分子驱动因素对于开发向疗法至关重要.
- 之前的研究表明,与初级骨髓MM相比,EMD具有独特的生物特征.
研究的目的:
- 为了研究EMD在多发性骨髓瘤中独特的分子格局.
- 为了确定关键的遗传变化和驱动EMD病变的途径.
- 为了比较EMD瘤的基因组资料与匹配的骨髓吸血样本.
主要方法:
- 在EMD瘤组织 (n=18) 和骨髓吸收物 (BMA) (n=20) 上进行了整体外体序列测定 (WES).
- 分析了六名患者的EMD和BMA样本,以进行直接的分子比较.
- 评估了基因组复杂度指标,包括瘤突变负担和副本数量改变.
主要成果:
- 在EMD中,MAPK路径突变的流行率高 (94%),而BMA (60%).
- 在NRAS,KRAS和BRAF中常见的突变在EMD中经常是克隆性的.
- 与BMA相比,EMD样本的基因组复杂性显著提高,瘤突变负担增加,以及1q增益/放大.
结论:
- 带有外骨髓性疾病的多发性骨髓瘤具有独特的分子形状,其特点是频繁的MAPK通路激活.
- 在基因组上,EMD是复杂而异质的,主要是由关键瘤基因的克隆突变和瘤抑制剂的改变所驱动的.
- 这些发现强调了需要新的治疗策略,以针对EMD独特的分子脆弱性.
相关概念视频
MAPK Signaling Cascades
5.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.0K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
The Intrinsic Apoptotic Pathway
5.7K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.7K
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K


